Inclusion in major Russell indexes is generally viewed positively as it increases visibility to institutional investors, typically leads to increased trading volume and liquidity, and validates the company's market position. Index inclusion often results in passive fund inflows as index funds rebalance to include the newly added security.
Oramed Pharmaceuticals news
$4.69−1.26%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Oramed Pharmaceuticals
BenzingaJun 17, 8:55 AM ET▲ Positive
GlobeNewswire Inc.Mar 13, 8:00 AM ET▲ Positive
Gains significant equity ownership in Lifeward through shares and warrants, retains control of POD™ platform clinical development, and gains exposure to established medical technology revenue streams while maintaining focus on its oral insulin therapy development.
Also mentions ORMP
Articles that tag ORMP but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology